Trade deal corners local drug makers

Domestic drug makers should focus on the promotion of their leading OTC products to survive in an era of the free trade agreement, experts said.

They should pursue more profitable OTC field, away from the labor-intensive industry centering on sales and marketing, they said.

Local pharmaceutical companies have been largely dependent on producing and marketing generic drugs instead of inve...